The News Scroll 22 June 2021  Last Updated at 11:07 am | Source: PTI

Dr Reddy''s Laboratories launches Icosapent Ethyl Capsules in US

Dr Reddy''s Laboratories launches Icosapent Ethyl Capsules in US
outlookindia.com
1970-01-01T05:30:00+0530
New Delhi, Jun 22 (PTI) Dr Reddy''s Laboratories on Tuesday announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

The company has launched Icosapent Ethyl Capsules in 1 gram strength after approval by the US Food and Drug Administration (USFDA), Dr Reddy''s said in a regulatory filing.

Dr Reddy''s Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120''s count.

Dr Reddy''s Icosapent Ethyl Capsules, 1 gram, is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Shares of Dr Reddy''s were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE. SVK ANS ANS


Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI
Next Story :
Download the Outlook ​Magazines App. Six magazines, wherever you go! Play Store and App Store